About S-BIO
S-BIO is a company based in Hudson (United States) founded in 2005. S-BIO has completed 1 acquisition, including Ezose Sciences. S-BIO offers products and services including PrimeSurface® 3D Culture Spheroid plates, EZGlyco™ mAb-N Kit, and BlotGlyco® Glycan Purification Kit. S-BIO operates in a competitive market with competitors including Pluri, AIM Biotech, Celloid, The Well Bioscience and ExCel Matrix Biological Devices, among others.
- Headquarter Hudson, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name S*Bio Pte Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of S-BIO
S-BIO offers a comprehensive portfolio of products and services, including PrimeSurface® 3D Culture Spheroid plates, EZGlyco™ mAb-N Kit, and BlotGlyco® Glycan Purification Kit.
Plates for uniform spheroid formation in cell research applications.
Kit for preparing IgG glycans for efficient HPLC analysis.
Kit for glycan purification and labeling in biologics development.
Funding Insights of S-BIO
Detailed funding history for S-BIO
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by S-BIO
S-BIO has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Ezose Sciences.
Investment portfolio details for S-BIO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
High-throughput glycan analysis services were provided by Ezose Sciences.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for S-BIO
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - S-BIO
Detailed financials for S-BIO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
S-Bio Comparisons
Peer comparison for S-BIO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of S-BIO
S-BIO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pluri, AIM Biotech, Celloid, The Well Bioscience and ExCel Matrix Biological Devices, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation cell-based products are developed across multiple industries.
|
|
| Locked | Locked | Locked |
Microfluidic 3D cell culture systems are developed and manufactured.
|
|
| Locked | Locked | Locked |
3D cell culture solutions for drug development are provided.
|
|
| Locked | Locked | Locked |
Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications.
|
|
| Locked | Locked | Locked |
Proprietary 3D cell culture technologies are provided for tissue engineering.
|
Detailed competitors of S-BIO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on S-Bio
Complete news archive for S-BIO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about S-BIO
S-BIO was founded in 2005.
S-BIO is headquartered in Hudson, United States.
Shigeru Hayashi is the current CEO of S-BIO.
S-BIO, a division of Sumitomo Bakelite Co., was established in 2005 and is headquartered in Hudson, United States. High-throughput glycan analysis services and related kits are provided for research applications in the biotechnology sector. Additionally, 3D cell culture plates featuring various well shapes are supplied to support advanced cell-based studies. Operations focus on analytical tools and materials for scientific workflows.
S-BIO's top competitors include Pluri, Celloid and ExCel Matrix Biological Devices.
S-BIO offers PrimeSurface® 3D Culture Spheroid plates, EZGlyco™ mAb-N Kit, and BlotGlyco® Glycan Purification Kit.
S-BIO has made 1 acquisition, including Ezose Sciences.